About Curia
Curia is a company based in Eschborn (Germany) founded in 2019. It operates as a HealthTech and Freemium. Curia offers products and services including Curia App, Info Feed, Clinical Trials, and Cancer Twin. Curia operates in a competitive market with competitors including Evidation, myTomorrows, Antidote, SubjectWell and Belong, among others.
- Headquarter Eschborn, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Innoplexus Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curia
Curia offers a comprehensive portfolio of products and services, including Curia App, Info Feed, Clinical Trials, and Cancer Twin.
An app supporting cancer patients with information.
Curated content is provided for cancer treatment support.
Access to global clinical trials is facilitated here.
Connections with similar cancer patients are enabled privately.
Funding Insights of Curia
Investors in Curia
Curia has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include K-Startup Grand Challenge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sector-agnostic acceleration is provided to startups through global programs.
|
Locked | Locked | Locked |
Investor details for Curia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Curia
Investment portfolio details for Curia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Curia
Detailed financials for Curia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Curia Comparisons
Peer comparison for Curia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Curia
Curia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evidation, myTomorrows, Antidote, SubjectWell and Belong, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Real-world health data is provided for research and decisions.
|
|
| Locked | Locked | Locked |
Platform provides access to drugs in development to patients and physicians
|
|
| Locked | Locked | Locked |
Provider of search engine tool for patients to explore, understand and access clinical trials.
|
|
| Locked | Locked | Locked |
Clinical trials marketplace for patient recruitment solutions is provided.
|
|
| Locked | Locked | Locked |
AI-enabled platform sources candidates for inclusive employment of disabled individuals.
|
|
| Locked | Locked | Locked |
Patients for clinical trials are identified through a dedicated platform.
|
Detailed competitors of Curia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Curia
Complete news archive for Curia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curia
Curia was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Curia is headquartered in Eschborn, Germany. It is registered at Eschborn, Hesse, Germany.
Holger Alexander Otto Hoffmann is the current CEO of Curia.
A digital solution is offered by Curia to support cancer patients throughout their treatment journey. Comprehensive, unbiased information is curated to assist patients in making informed decisions. Features such as connecting with similar patients, accessing clinical trials, finding treatments, and consulting experts are included. The healthcare sector, specifically digital health, is targeted with a patient-centric approach. AI technology is utilized to personalize content based on cancer type and stage. Community engagement and research involvement are encouraged through the platform.
Curia's top competitors include Evidation, myTomorrows and Dyania Health.
Curia offers Curia App, Info Feed, Clinical Trials, and Cancer Twin.
Curia has 1 investor. Key investors include K-Startup Grand Challenge.